首页>
外国专利>
METHODS AND KITS FOR DETERMINING WHETHER A PATIENT WITH CIRRHOSIS IS AT RISK OF HAVING CLINICALLY SIGNIFICANT PORTAL HYPERTENSION
METHODS AND KITS FOR DETERMINING WHETHER A PATIENT WITH CIRRHOSIS IS AT RISK OF HAVING CLINICALLY SIGNIFICANT PORTAL HYPERTENSION
展开▼
机译:确定患有肝硬化患者是否有临床上显着的门脉高压症的风险的方法和试剂盒
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a method for determining whether a patient with cirrhosis is at risk of having clinically significant portal hypertension comprising the steps consisting of i) quantifying the levels of leuko-endothelial (CD31+/41-), pan- leukocyte (CDl la+), lymphocyte (CD4+), erythrocyte (CD235a+) and hepatocyte-derived (cytokeratin- 18+) microparticles in a blood sample obtained from the patient and ii) comparing said levels with predetermined reference values wherein a difference between the levels quantified at step i) and the predetermined reference values is indicative whether the patient is at risk of having clinically significant portal hypertension.
展开▼